Ageing Emerges as Leading Cancer Risk Factor, Outranking Smoking and Sun Exposure
If you ask most individuals about the primary causes of cancer, typical responses include smoking, alcohol consumption, sun exposure, or hair dye. However, groundbreaking research reveals the most significant risk factor is something entirely unavoidable: the natural process of ageing. This universal condition affects everyone and has now been identified as the foremost contributor to cancer development globally.
The Demographic Reality of Cancer Care
This revelation carries profound implications as older adults represent the fastest-growing population segment both in Canada and worldwide. Current projections indicate that by 2068, approximately 29 percent of Canadians will be aged 65 or older. With cancer ranking among the most prevalent diseases affecting older populations, healthcare systems face mounting pressure to develop specialised geriatric oncology services that address this demographic shift effectively.
International medical guidelines, including those established by the American Society of Clinical Oncology, now recommend comprehensive geriatric assessments for all older adults before determining cancer treatment plans. These assessments typically involve consultation with geriatric specialists who evaluate how potential treatments might impact cognitive function, physical capabilities, existing health conditions, and remaining life expectancy.
Current State of Geriatric Oncology in Canada
Despite clear medical guidelines, Canada currently maintains only a handful of specialised geriatric oncology clinics. The pioneering facility operates at Montreal's Jewish General Hospital, closely followed by the Older Adult with Cancer Clinic at Toronto's Princess Margaret Cancer Centre under the leadership of researcher Shabbir Alibhai. Promising developments are underway in Ontario and Alberta, where new geriatric oncology programs are reportedly in development stages.
Remarkably, British Columbia currently lacks any specialised cancer services tailored specifically for older adults. Over the past five years, researcher Kristen Haase has collaborated with colleagues to assess service gaps through extensive community engagement involving over 100 cancer community members, including patients, caregivers, volunteers, and healthcare professionals.
Financial and Systemic Benefits
Research led by Shabbir Alibhai demonstrates that specialised geriatric oncology clinics generate substantial cost savings of approximately $7,000 per older adult patient. When extrapolated across Canada's annual cancer diagnoses among elderly populations, these savings could significantly benefit public healthcare systems. Yet despite compelling evidence, geriatric assessment remains outside routine cancer care protocols nationwide.
Barriers to Comprehensive Geriatric Cancer Care
Multiple obstacles hinder widespread implementation of geriatric oncology services across Canada. While cost considerations initially appear prohibitive, research confirms expenses are offset by demonstrated savings. More pressing challenges include severe shortages of geriatric specialists, though promising alternatives exist through nurse-led assessment models that leverage expanding nurse practitioner roles across Canadian healthcare.
Systemic inertia represents another significant barrier, as oncology care models have remained largely unchanged for over three decades despite rapid therapeutic advancements. The healthcare system has proven more adaptable to new medications and surgical techniques than to innovative care models like comprehensive geriatric assessment.
Perhaps the most insidious obstacle involves deeply embedded ageism within healthcare systems. Age-based discrimination remains prevalent across multiple sectors, creating acceptance gaps that would be considered outrageous in pediatric care contexts. The research community emphasizes that while specialized services cannot accommodate all older cancer patients, targeted programs for the most vulnerable individuals could maximize both quality-of-life improvements and financial efficiencies.
As cancer diagnoses among older populations continue rising, healthcare systems face increasing pressure to innovate care models that prioritize those most likely to benefit from tailored geriatric oncology services. If personal narratives and international guidelines prove insufficient motivation for policymakers, perhaps demonstrable cost savings will finally catalyze necessary systemic changes.
